A Nomogram Based on Apelin-12 for the Prediction of Major Adverse Cardiovascular Events after Percutaneous Coronary Intervention among Patients with ST-Segment Elevation Myocardial Infarction

Abstract

Objective. This study aimed to establish a clinical prognostic nomogram for predicting major adverse cardiovascular events (MACEs) after primary percutaneous coronary intervention (PCI) among patients with ST-segment elevation myocardial infarction (STEMI). Methods. Information on 464 patients with STEMI who performed PCI procedures was included. After removing patients with incomplete clinical information, a total of 460 patients followed for 2.5 years were randomly divided into evaluation (n = 324) and validation (n = 136) cohorts. A multivariate Cox proportional hazards regression model was used to identify the significant factors associated with MACEs in the evaluation cohort, and then they were incorporated into the nomogram. The performance of the nomogram was evaluated by the discrimination, calibration, and clinical usefulness. Results. Apelin-12 change rate, apelin-12 level, age, pathological Q wave, myocardial infarction history, anterior wall myocardial infarction, Killip’s classification > I, uric acid, total cholesterol, cTnI, and the left atrial diameter were independently associated with MACEs (all P<0.05). After incorporating these 11 factors, the nomogram achieved good concordance indexes of 0.758 (95%CI = 0.707–0.809) and 0.763 (95%CI = 0.689–0.837) in predicting MACEs in the evaluation and validation cohorts, respectively, and had well-fitted calibration curves. The decision curve analysis (DCA) revealed that the nomogram was clinically useful. Conclusions. We established and validated a novel nomogram that can provide individual prediction of MACEs for patients with STEMI after PCI procedures in a Chinese population. This practical prognostic nomogram may help clinicians in decision making and enable a more accurate risk assessment.

Clinical Nomogram to Predict Major Adverse Cardiac Events in Acute Myocardial Infarction Patients within 1 Year of Percutaneous Coronary Intervention

“…Human functions and physiological processes degrade to different degrees as we age, and age is more likely to be linked with a range of other illnesses. Furthermore, the coronary arteries of older individuals are often accompanied with widespread vascular infections and significant calcification, reducing the likelihood of their getting vascular repair [18]. In the development of coronary artery disease, myocardial infarction, and cardiac death, diabetes mellitus is an independent risk factor.…”

MicroRNA-146a Serves as a Biomarker for Adverse Prognosis of ST-Segment Elevation Myocardial Infarction

“…Human functions and physiological processes decline with age, which is likely linked with a variety of other illnesses. Furthermore, the coronary arteries of older individuals are often characterized by widespread venereal infections and significant calcification, lowering the likelihood of effective vascular repair ( 40 ). Hypertension and DM are traditional risk factors for cardiovascular events ( 41 ).…”

Nomogram to predict 3-month unfavorable outcome after thrombectomy for stroke

“…However, these scores still have many shortcomings, the most important of which is that the performance for individualized prediction of outcome is limited by the use of categorization of continuous variables, such as age, glucose level, ASPECT (Alberta Stroke Program Early CT) score, and National Institutes of Health Stroke Scale (NIHSS) score. Nomogram is a computational tool that can generate numerical probabilities of clinical events based on each patient’s personal profile by creating graphical representation of statistical prediction models [ 6 ], which has demonstrated significant advantages over traditional staging systems and has been used to predict many diseases, such as pneumonia, myocardial infarction, and cancer [ 7 – 9 ]. Based on its advantage to use continuous variables, nomogram is a better visual tool than the above scores to predict the 3-month outcomes after MT.…”